Researchers develop novel exosome-based drug delivery system to treat Alzheimer’s disease
A research team led by Hong Kong Baptist University (HKBU) has developed a novel drug delivery system for Alzheimer’s disease (AD).
A research team led by Hong Kong Baptist University (HKBU) has developed a novel drug delivery system for Alzheimer’s disease (AD).
Scientists have created the first extensive map showing how all possible genetic changes can affect health in the gene DDX3X, leading to valuable insights into the underlying mechanisms of neurodevelopmental…
The Heart Foundation welcomes the passing of the Public Health (Tobacco and Other Products) Bill 2023 in Parliament today as a critical action to prevent and further reduce the heart…
Study found that pregnant mothers with COVID-19 face a significantly higher risk of severe maternal morbidity (SMM), including adult respiratory distress syndrome and acute renal failure, emphasizing the urgent need…
Study in The American Journal of Clinical Nutrition found an association between dairy intake and prediabetes risk, highlighting that low-fat milk consumption may increase prediabetes risk, while high-fat yogurt is…
Study shows two ChatGPT large language models (LLMs) outperformed human neurology students in an entrance exam, with one model achieving 85% accuracy, demonstrating their potential in clinical neurology and medical…
Using machine learning, researchers successfully distinguished factors of healthy aging from chronic disease risks by analyzing health data across various ages, finding key markers like neutrophil counts and alkaline phosphatase…
Study shows that Guayusa extract and Nordic Lion’s Mane (LM) improve subjective cognitive perception and objective cognitive performance, highlighting their potential benefits in enhancing cognitive functions and mood.
This study in Scientific Reports reveals that symptoms of community-acquired bacterial meningitis (CABM) vary between children and adults, emphasizing the need for tailored approaches in early diagnosis and treatment to…
Study demonstrates that inhibiting stromal class I histone deacetylases (HDACs) can effectively slow down pancreatic cancer progression, shedding light on a new therapeutic approach targeting the tumor microenvironment.